DRIO
DarioHealth Corp.
There isn't enough reported data to score DRIO yet.
DRIO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Unavailable |
DRIO's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
DRIO PE Valuation
DRIO has no meaningful PE right now: it lost money over the past year.
DRIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| -- | |
| Limited | |
| High |
Analysts expect DRIO's losses to shrink, with revenue growing.
DRIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$5.60 | +$33.20 |
| Q2 2024 | -$20.40 | +$21.40 |
| Q1 2024 | -$33.60 | +$11.40 |
| Q4 2023 | -$38.60 | +$12.20 |
DRIO is still losing money, but far less than before: $5.60 per share over the past year, against $50.80 at its worst in late 2022.
DRIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.3M | +6.1% |
| Q2 2026 | $5.2M | -3.6% |
| Q1 2026 | $5.6M | -17% |
| Q4 2025 | $5.2M | -31% |
| Q3 2025 | $5M | -33% |
| Q2 2025 | $5.4M | -14% |
| Q1 2025 | $6.8M | +17% |
| Q4 2024 | $7.6M | +110% |
DRIO's revenue is recovering but still below its 2022 peak: $5M last quarter, up 6.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -151% | +38 points |
| Q2 2026 | -125% | +46 points |
| Q1 2026 | -131% | +8.5 points |
| Q4 2025 | -164% | -10 points |
| Q3 2025 | -189% | -27 points |
| Q2 2025 | -171% | +88 points |
| Q1 2025 | -139% | +171 points |
| Q4 2024 | -153% | +240 points |
DRIO's operating margin was −151% last quarter, up 38 points from the same quarter a year ago.
DRIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.6M | +$1.8M |
| Q2 2026 | -$6.1M | -$46K |
| Q1 2026 | -$6.1M | +$648K |
| Q4 2025 | -$5.9M | +$840K |
| Q3 2025 | -$7.4M | -$2K |
| Q2 2025 | -$6.1M | +$5.3M |
| Q1 2025 | -$6.7M | +$6.5M |
| Q4 2024 | -$6.8M | +$671K |
DRIO has burned cash in almost every quarter: −$24M over the past year, against −$27M the year before.
DRIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +29% | +2.7M shares |
| 1 year | +386% | +9.6M shares |
| 3 years | +756% | +10.7M shares |
| 5 years | +1620% | +11.4M shares |
DRIO has 12M diluted shares, up 386% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
DRIO Net Leverage
DRIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DRIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.8 | Oversold |
| Stochastic | 1.0 | Oversold |
DRIO's weekly RSI is 20 (oversold) and its Stochastic is 1 (oversold).
DRIO PE vs Healthcare Sector
DRIO has no meaningful PE right now: it lost money over the past year.
DRIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.31 | 62% below |
| 20 week MA | $6.07 | 73% below |
| 50 week MA | $8.02 | 79% below |
| 100 week MA | $10.7 | 85% below |
| 200 week MA | $28.9 | 94% below |
DRIO is in a downtrend: it's below all five of its weekly moving averages, and 94% below its 200-week average.
DRIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $126.0 | $263.4 | +109% |
| 2021 | $263.4 | $273.0 | +3.6% |
| 2022 | $273.0 | $79.8 | -71% |
| 2023 | $79.8 | $34.4 | -57% |
| 2024 | $34.4 | $13.9 | -60% |
| 2025 | $13.9 | $10.0 | -28% |
| 2026 YTD | $10.0 | $1.65 | -84% |
DRIO has finished four years in a row lower, and it's down 84% so far in 2026.